List of Medicines for Brand Consideration (LMBC)

This List of Medicines for Brand Consideration includes medicines prescribers should consider prescribing by brand as well as active ingredient, if clinically necessary for the treatment of their patient. For example, in situations where formulations are not interchangeable due to variations in delivery of the active ingredient, prescribers should consider specification by brand for patient safety.

list of medicine for brand consideration december 2021

Downloads

List of Medicines for Brand Consideration (LMBC)

Download PDF (931.34 KB)

Accessibility - We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Copyright - Unless stated otherwise, materials provided are covered by a Creative Commons Attribution-Non-Commercial-Share Alike (BY-NC-ND) 4.0 International License.

 

Description

The List of Medicines for Brand Consideration includes medicines prescribers should consider prescribing by brand as well as active ingredient, if clinically necessary for the treatment of their patient. 

The List of Medicines for Brand Consideration and the List of Excluded Medicinal Items are supplemental to the Active ingredient prescribing – User guide for Australian prescribers, a resource that supports prescribers to prescribe medicines by the active ingredient with best practice guidance for specification of brand. 

Please contact medsafety@safetyandquality.gov.au for previous iterations of the List of Medicines for Brand Consideration.

Publication year
2022
Resource type
Guide, user guide or guidelines